Table 2.

Outcomes of S. aureus bacteremia (MRSA and MSSA) by Vancomycin Trough

	Trough ≤ 10 μg/ml (n=55)	Trough 10–≤15 μg/ml (n=33)	Trough > 15 μg/ml (n=39)	P value
Median Age, Months (IQR)	15.6 (1.2–96)	2.4 (0.1–10.3)	9.4 (0.3–169.2)	0.3
Infectious Diagnosis of Endocarditis	7 (12.7)	10 (30.3)	4 (10.3)	0.07
Median Duration of Bacteremia, Days (IQR)	2 (1–4)	2.5 (1–5)	2 (1–4)	0.4
Median Time to Resolution of Fever, Days (IQR)	2 (1–4)	3 (2–4)	2 (1–5)	0.2
Median Length of Hospital Stay, Days (IQR)	17.5 (10–44)	47.5 (24–104)	43.5 (25–89)	0.01
AKI	9 (16.2)	11 (33.3)	24 (61.5)	<0.001
S. aureus Attributable Mortality	2 (3.6)	3 (9.1)	8 (20.5)	0.02